Revise a provision related to unauthorized distribution of fentanyl and provide a penalty therefor.
HB 1230 revises South Dakota’s controlled-substances law governing unauthorized manufacture, distribution, dispensing, and possession with intent to distribute Schedule I or II drugs, with a specific focus on fentanyl. The bill keeps the baseline offense as a Class 4 felony, but adds and clarifies enhanced penalties when aggravating circumstances are present, such as possession of cash, firearms, pill presses, packaging materials, precursor chemicals, lab equipment, or transaction records. It also creates a higher felony tier when the offense involves four milligrams or more of fentanyl, with mandatory prison terms increasing based on the amount involved.
The bill also strengthens penalties for distribution to minors and for drug sales that result in death. Distribution to a minor remains a Class 2 felony, but the mandatory minimum prison terms are increased for first and repeat offenses. If a person intentionally distributes a controlled substance for consideration and another person dies as a direct result, the offense is elevated to a Class 2 felony, with even harsher treatment if aggravating factors apply, if the substance is fentanyl and the distributor knew it, or if the decedent is a minor. The bill also authorizes a civil penalty of up to $10,000 in addition to criminal punishment.
HB 1230 amends § 22-42-2 of the South Dakota Codified Laws and increases criminal exposure for fentanyl-related distribution and other controlled-substance offenses. It creates new fentanyl-specific felony thresholds, mandatory minimum sentences, and enhanced penalties for distribution to minors and drug-induced deaths, while also allowing a civil fine. The bill affects prosecutors, defendants, courts, and correctional facilities by expanding mandatory incarceration and limiting sentencing alternatives such as suspended sentences and probation-based reductions.
The bill appears to have broad legislative support, passing committee and floor votes overwhelmingly with only a small number of dissenting votes in the House. The recorded votes show strong bipartisan agreement on the need to strengthen fentanyl penalties and address overdose-related harms. The absence of committee transcript discussion suggests little publicly recorded controversy in the available materials, and the final enrolled act indicates the measure advanced successfully through both chambers.
The main points of contention likely center on the severity of mandatory minimum sentences, especially the escalation tied to fentanyl quantity, repeat offenses, and deaths resulting from distribution. Critics of such measures typically argue that mandatory prison terms reduce judicial discretion and may not address addiction or trafficking networks effectively, while supporters view the bill as a necessary deterrent and a response to the fentanyl overdose crisis. The vote margins suggest any disagreement was limited, with only a small minority opposing final passage.